POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY

POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY

Bibliographic Details
Main Authors: A. HAVASI, H.J. Lachmann, N. Leung, S. Kumar, A.J. Waxman, A.D. Wechalekar, K.S. Gries, X. Qin, H. Pei, N. Tran, B.M. Weiss, V. Sanchorawala
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024921009785

Internet

http://www.sciencedirect.com/science/article/pii/S2468024921009785

Similar Items